Achaogen, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2004-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.achaogen.com
A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
- First Posted Date
- 2017-09-01
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03270553
- Locations
- 🇺🇸
Clinical Site, Lincoln, Nebraska, United States
A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin
- First Posted Date
- 2017-06-06
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT03177278
- Locations
- 🇺🇸
Clinical Site, Lincoln, Nebraska, United States
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03163550
- Locations
- 🇦🇺
Clinical Site, Perth, Australia
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2018-08-23
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 609
- Registration Number
- NCT02486627
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-28
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT01970371
A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2013-07-01
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT01870245
- Locations
- 🇺🇸
Investigational Site, Overland Park, Kansas, United States
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2013-01-21
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01597947
- Locations
- 🇺🇸
Investigational Site, Durham, North Carolina, United States
A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2012-05-09
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT01514929
- Locations
- 🇺🇸
Investigational Site, West Bend, Wisconsin, United States
PK Study of ACHN-490 Injection in Renally Impaired Subjects
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2012-08-23
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01462136
A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Achaogen, Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT01096849
© Copyright 2024. All Rights Reserved by MedPath